Anonymize prospectus supplement drafts for underwriter and legal review – CCPA/HIPAA-compliant de-identification per 15 USC §77j
A prospectus supplement is the Securities Act of 1933 (§77j) document that supplies deal-specific pricing and terms for a shelf offering under a registration statement — a shelf process Rule 415 has permitted since 1983. Well-known seasoned issuers, defined under Rule 405 as those with a public float above $700 million, can price a shelf takedown within hours of filing the supplement. Prospectus supplements identify named selling shareholders, underwriters, and deal-specific counterparties. anonym.legal pseudonymizes those identifiers in supplement drafts so pricing-committee and legal teams can review terms before the pricing date.
When this applies
Apply this workflow when draft prospectus supplements for equity, debt, or convertible securities shelf offerings are circulated to the pricing committee, syndicate desk, or legal team before the offering pricing date where named selling-shareholder or counterparty identities are not required by the reviewer.
How anonym.legal handles it
- Upload the draft prospectus supplement in PDF or DOCX format to anonym.legal.
- The engine identifies named selling shareholders, lead underwriters, co-managers, and named counterparties in the supplement.
- Each named individual and entity is pseudonymized consistently across the front cover, selling-shareholder table, underwriting section, and plan of distribution.
- Pricing terms, offering size, underwriting discount, use of proceeds, and maturity date (for debt offerings) are retained as structural content.
- The base prospectus incorporated by reference is processed separately if required for consistent pseudonymization.
- The reversible mapping is stored encrypted for re-identification at pricing.
- The pseudonymized supplement draft is exported for committee and legal review.
What you provide
- Draft prospectus supplement in PDF or DOCX format
- Preliminary pricing term sheet if circulated separately
- Scope instruction identifying which named parties require pseudonymization
Limitations & cautions
- anonym.legal does not assess whether the prospectus supplement satisfies Securities Act §77j delivery requirements or SEC rule shelf-eligibility conditions; those determinations require securities counsel. A shelf registration statement filed under Rule 415 (permanently adopted in 1983) can remain effective for up to three years before it must be renewed, a limit introduced by the SEC's 2005 Securities Offering Reform.
- Prospectus supplements for complex structured products may contain counterparty-referencing terms that require individual legal review beyond automated pseudonymization.
- The tool does not file or transmit the prospectus supplement to the SEC or any clearance system. Issuers that fall short of the $700 million WKSI float threshold can still qualify by having issued at least $1 billion in non-convertible securities in primary offerings over the prior three years.
- Re-identification is required before the final supplement is filed and printed for distribution to investors.
FAQ
Can this workflow handle both equity and debt prospectus supplements?
Yes. The workflow applies to equity shelf supplements, debt shelf supplements, and convertible-note supplements alike. The pseudonymization logic covers named parties in both the front matter and the plan-of-distribution section regardless of security type, whether the issuer relies on WKSI status or the baby-shelf rule capping Form S-3 primary-offering sales at one-third of public float for issuers under the $75 million float threshold.
Will the underwriting syndicate table be pseudonymized?
Yes. Named lead underwriters, co-managers, and their share allocations in the syndicate table are pseudonymized at the entity level while the underwriting discount and stabilization terms are preserved as structural content.
Is this workflow relevant for ATM (at-the-market) offering program supplements?
Yes. ATM equity distribution agreement supplements naming the sales agent are processed with consistent pseudonymization. The offering mechanics, pricing methodology, and distribution-plan description are preserved in plain text, including any WKSI-eligible issuer's $700 million-plus public-float basis for using the shelf process.